Novel antibiotics named kigamicin A, B, C, D, and E were discovered from the culture broth of Amycolatopsis sp. ML630-mF1 by their selective killing activity against PANC-1 cells only under a nutrient starved condition. Under a condition of nutrient starvation, kigamicins A, B, C, and D inhibited PANC-1 cell survival at 100 times lower concentration than in normal culture. Kigamicins showed antimicrobial activity against Gram-positive bacteria including methicillin resistant Staphylococcus aureus (MRSA). Kigamicin D inhibited the growth of various mouse tumor cell lines at IC50 of about 1 μg/ml.
CITATION STYLE
Kunimoto, S., Lu, J., Esumi, H., Yamazaki, Y., Kinoshita, N., Honma, Y., … Takeuchi, T. (2003). Kigamicins, novel antitumor antibiotics. I. Taxonomy, isolation, physico-chemical properties and biological activities. Journal of Antibiotics, 56(12), 1004–1011. https://doi.org/10.7164/antibiotics.56.1004
Mendeley helps you to discover research relevant for your work.